| |
 |
QuickSCREEN™
PRO 5
Multi-Drug, Five Panel Test Card with Automatic
Timing Device

An easy, fast and accurate one-step five (5)
panel drug screening test for determining the presence and use of the five
most abused illicit and prescription drugs. Recommended for use when the
specific drug of abuse is unknown or multiple drug use is suspected. 98%
accurate and FDA approved.
|
INTENDED USE
For a comprehensive
discussion on drug of abuse testing including typical detection time periods
see the DRUG
TESTING FAQ |
A visual one-step five (5) panel immunoassay* for the
simultaneous, qualitative detection of multiple drugs and metabolites in human urine using
one test device. This all inclusive testing card is used to obtain a rapid, visual,
qualitative result indicating drug usage or abuse within a few minutes. This product will
not test for quantitative measurements of drug concentrations in the body but will
indicate their presence at or above minimum concentrations established by the NIDA and the
World Health Organization. The QuickScreen Pro Drug testing device is approved by
the FDA. This test
is recommended as an all inclusive scan when drug use is suspected but the
specific target drug is unknown.
•
Parental Control and Home Zero Tolerance Programs
•
Random Drug
Screening of Employees
•
School and Professional Athletic Programs
•
All Academic and Business "Drug Free Environment"
Policies
•
Routine Medical Exams and Patient Profiles
•
Pre-Employment Screening
•
Vehicle and Heavy Equipment Operation
•
Halfway House, Drug Counseling or Treatment Programs
•
Probation and Law Enforcement
|
The QuickScreen Pro
5 Drug Test Card is a lateral flow, one-step panel immunoassay for the qualitative
detection of Amphetamines, benzoylecgonine (cocaine metabolite),
Methamphetamines (including Ecstasy*),
Opiates (morphine/heroin metabolite) and 11-nor-D 9 Tetrahydrocannibinol-9-carboxylic acid
(marijuana) in human urine at the following cut-off concentrations based on the
following Federal
(NIDA) guidelines.
*While Methamphetamine tests
will generally detect MDMA (Ecstasy), an MDMA specific
test is recommended when screening specifically for MDMA or Ecstasy use.
AMP
|
Amphetamines
|
1000 ng/ml
|
COC
|
Cocaine/Benzoylecgonine
|
300 ng/ml
|
THC
|
Marijuana
|
50 ng/ml
|
OPI
|
Opiates/Morphine/Heroin
|
2000 ng/ml
|
PCP
|
Phencyclidine
|
25 ng/ml
|
M-AMP |
Methamphetamines
|
500 ng/ml
|
Urine based screening test for
drugs of abuse range from simple immunoassay test to complex analytical procedures. The
speed and sensitivity of immunoassays have made them the most widely accepted method for
screening urine for drugs of abuse. A
visual one-step five panel urine test can be administered any time, at any place, and
provide a qualitative and definitive "yes or no" answer in three to four (3-4)
minutes (8 minutes for THC due to high sensitivity levels) without the costly and time
consuming process of clinical analysis. See a
short slide presentation
and
overview
of the
QuickScreen™ Pro 5.
 The QuickScreen
Pro 5 Drug Test Card is based on the principle of the highly
specific immunochemical reactions of antigens and antibodies which are used for the
analysis of specific compounds in biological fluids. The QuickScreen Pro Drug Test Card is a fast visual, competitive panel immunoassay that can be used for
the simultaneous, qualitative detection of amphetamines, benzoylecgonine (cocaine),
methamphetamine (including "crystal-meth"
and "Ecstasy"),
opiates (morphine/codeine), and Tetrahydrocannibinol-9-carboxylic
acid (marijuana) in human urine. When used in accordance with the instructions
(included), the test device will give a rapid visual confirmation as to the
presence of drugs in the system at the standard cut-off levels indicated above.
The graphic to the right shows the development of several possible results in
using the test
A brief
slide show
gives a basic
overview on the QuickScreen™
Pro 5.
Drugs and drug metabolites remain at detectable levels in the human body for
various periods of time. Information on typical "time after use" periods at which drug and drug
metabolites can be detected is illustrated in a chart located on the
FAQ page. For information on the chemistry of the test please see the
Technical Properties
page. For information
on usage and result interpretation of the test
go to Test Usage. For
comprehensive background information on drug testing see the
Drug Testing Q&A. A chart summarizing the benefits of drug screening tests can be found at
Usage Benefits For testing suspect urine samples for dilution, adulteration or tampering please
the Adulteration Test page.
AVAILABILITY AND ORDERING
The
QuickScreen Pro Drug Test Card is presently available in packs of 1, 3, 6, 12, 25,
50
and 100 test packs. For quantities exceeding 250 units please
contact us for special volume pricing. Complete use and background information including laboratory testing results, cross reaction charts, drug characteristics and other useful information is included with each test kit. The
QuickScreen Pro Drug Test Card is approved by the FDA, method and claims.
Description |
Packaging |
Quantity |
Cost |
|
QuickScreen
Pro 5 Panel Drug Test |
Each/Sealed |
1 Test
Pack |
$14.90 |
 |
|
|
3 Test
Pack |
$36.00 |
 |
|
|
6 Test
Pack |
$60.00 |
 |
|
|
12 Test
Pack |
$99.00 |
 |
|
|
25 Test
Pack |
$180.00 |
 |
|
|
50 Test
Pack |
$325.00 |
 |
|
|
100
Test Pack |
$575.00 |
 |
*If the
order buttons are absent or inoperable, please use the
pricing overview page to order. |
*This
immunoassay provides a preliminary, first-line analytical test result. A more specific
alternative chemical method can be used in order to obtain a confirmed laboratory
analytical result. Gas chromatography/mass spectrometry (GCIMS) has been established as
the preferred confirmatory method by the National Institute on Drug Abuse (NIDA). For
specific situations where laboratory confirmation of positive results is required, please
refer to the QuickScreen Pro Drug Test page. Clinical
consideration and professional judgment should be applied to any drug of abuse test
result, particularly when preliminary positive results are indicated.

|